Invention Grant
- Patent Title: Antibody drug conjugates (ADC) that bind to 161P2F10B proteins
-
Application No.: US14106444Application Date: 2013-12-13
-
Publication No.: US09308278B2Publication Date: 2016-04-12
- Inventor: Michael Torgov , Robert Kendall Morrison , Aya Jakobovits , Jean Gudas , Zili An
- Applicant: AGENSYS, INC.
- Applicant Address: US CA Santa Monica
- Assignee: Agensys, Inc.
- Current Assignee: Agensys, Inc.
- Current Assignee Address: US CA Santa Monica
- Agency: Morrison & Foerster LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K47/48 ; C07K16/30 ; A61K39/395 ; A61K39/00
Abstract:
Antibody drug conjugates (ADC's) that bind to 161P2F10B protein are described herein. 161P2F10B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC's of the invention provide a therapeutic composition for the treatment of cancer.
Public/Granted literature
- US20140194601A1 ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 161P2F10B PROTEINS Public/Granted day:2014-07-10
Information query
